loadpatents
name:-0.03502893447876
name:-0.012794017791748
name:-0.012222051620483
Poirier; Nicolas Patent Filings

Poirier; Nicolas

Patent Applications and Registrations

Patent applications and USPTO patent grants for Poirier; Nicolas.The latest application filed is for "methods and compositions for modifying macrophage polarization into pro-inflammatory cells to treat cancer".

Company Profile
11.14.32
  • Poirier; Nicolas - Treillieres FR
  • Poirier; Nicolas - Nantes FR
  • Poirier; Nicolas - Stein CH
  • Poirier; Nicolas - Ville-la-Grand FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods And Compositions For Modifying Macrophage Polarization Into Pro-inflammatory Cells To Treat Cancer
App 20220298259 - Poirier; Nicolas ;   et al.
2022-09-22
Method for treating a pathological condition involving the activation or proliferation of CD127 positive cells with an anti-CD127 antibody
Grant 11,440,964 - Poirier , et al. September 13, 2
2022-09-13
Methods For Promoting T Cells Response
App 20220281983 - CHIFFOLEAU; Elise ;   et al.
2022-09-08
Method and Compositions for Inducing Differentiation of Myeloid Derived Suppressor Cell to Treat Cancer and Infectious Diseases
App 20220281993 - Poirier; Nicolas ;   et al.
2022-09-08
ANTI-SIRPa ANTIBODIES AND THEIR THERAPEUTIC APPLICATIONS
App 20220281991 - POIRIER; Nicolas ;   et al.
2022-09-08
USES OF ANTI-SIRPg ANTIBODIES
App 20220242951 - POIRIER; NICOLAS ;   et al.
2022-08-04
Methods for promoting t cells response by administering an antagonist of human c-type lectin-like receptor 1 (CLEC-1)
Grant 11,365,257 - Chiffoleau , et al. June 21, 2
2022-06-21
Humanized anti-human-PD-1 antibody and its use in cancer treatment
Grant 11,352,430 - Poirier , et al. June 7, 2
2022-06-07
Anti-SIRPa antibodies and their therapeutic applications
Grant 11,279,766 - Poirier , et al. March 22, 2
2022-03-22
Bifunctional Anti-pd-1/sirpa Molecule
App 20220056135 - POIRIER; NICOLAS ;   et al.
2022-02-24
Bifunctional Molecule Directed Against Human Pd-1
App 20220025050 - POIRIER; NICOLAS ;   et al.
2022-01-27
Non-antagonistic antibodies directed against the alpha chain of the IL7 receptor extracellular domain and use thereof in cancer treatment
Grant 11,230,602 - Poirier , et al. January 25, 2
2022-01-25
Antibodies And Polypeptides Directed Against Cd127
App 20210395376 - POIRIER; Nicolas ;   et al.
2021-12-23
Humanized Anti-human-pd-1 Antibody
App 20210355225 - POIRIER; NICOLAS ;   et al.
2021-11-18
Antibodies and polypeptides directed against CD127
Grant 11,098,128 - Poirier , et al. August 24, 2
2021-08-24
Modified Anti-sirpa Antibodies And Uses Thereof
App 20210179728 - POIRIER; Nicolas ;   et al.
2021-06-17
Anti-chemokin Like Receptor 1 Antibodies And Their Therapeutic Applications
App 20210147558 - POIRIER; NICOLAS ;   et al.
2021-05-20
Use Of Anti-human Sirpa V1 Antibodies And Method For Producing Anti-sirpa V1 Antibodies
App 20210040206 - POIRIER; Nicolas ;   et al.
2021-02-11
Method And Preparation For Sorting Out T Effector Cells Using Anti-cd127 Antibodies For Applications In Cell Therapy
App 20200362300 - VANHOVE; Bernard ;   et al.
2020-11-19
Non-antagonistic Antibodies Directed Against The Alpha Chain Of The Il7 Receptor Extracellular Domain And Use Thereof In Cancer Treatment
App 20200308288 - POIRIER; Nicolas ;   et al.
2020-10-01
Biomarkers For Assessing The Response Status For Treatment Of Inflammatory Condition Or Disease Affecting The Digestive Tract Su
App 20200181706 - POIRIER; Nicolas ;   et al.
2020-06-11
NEW USES OF ANTI-SIRPg ANTIBODIES
App 20190382483 - POIRIER; NICOLAS ;   et al.
2019-12-19
Antibodies Directed Against CD127
App 20190382497 - POIRIER; Nicolas ;   et al.
2019-12-19
Antibodies And Polypeptides Directed Against Cd127
App 20190375844 - POIRIER; Nicolas ;   et al.
2019-12-12
Methods For Promoting T Cells Response
App 20190309075 - CHIFFOLEAU; Elise ;   et al.
2019-10-10
Antibodies directed against CD127
Grant 10,428,152 - Poirier , et al. October 1, 2
2019-10-01
Anti-CD28 humanized antibodies
Grant 10,364,287 - Mary , et al.
2019-07-30
NEW ANTI-SIRPa ANTIBODIES AND THEIR THERAPEUTIC APPLICATIONS
App 20190127477 - POIRIER; Nicolas ;   et al.
2019-05-02
Methods And Compositions For Modifying Macrophage Polarization Into Pro-inflammatory Cells To Treat Cancer
App 20180312600 - Poirier; Nicolas ;   et al.
2018-11-01
Method and Compositions for Inducing Differentiation of Myeloid Derived Suppressor Cell to Treat Cancer and Infectious Diseases
App 20170247464 - Poirier; Nicolas ;   et al.
2017-08-31
Antibodies Directed Against CD127
App 20170129959 - POIRIER; Nicolas ;   et al.
2017-05-11
Anti-CD28 Humanized Antibodies
App 20170114136 - Mary; Caroline ;   et al.
2017-04-27
Anti-CD28 humanized antibodies
Grant 9,562,098 - Mary , et al. February 7, 2
2017-02-07
Antibodies directed against the alpha chain of IL7 receptor--their use for the preparation of drug candidates
Grant 9,447,182 - Brouard , et al. September 20, 2
2016-09-20
Anti-CD28 Humanized Antibodies
App 20150071916 - Mary; Caroline ;   et al.
2015-03-12
Dihydrofuran Derivatives As Insecticidal Compounds
App 20140343049 - Toueg; Julie Clementine ;   et al.
2014-11-20
Alkynyl derivatives as modulators of metabotropic glutamate receptors
Grant 8,883,826 - Bessis , et al. November 11, 2
2014-11-11
Antibodies Directed Against The Alpha Chain Of Il7 Receptor - Their Use For The Preparation Of Drug Candidates
App 20140308281 - Brouard; Sophie ;   et al.
2014-10-16
Anti-CD28 humanized antibodies
Grant 8,785,604 - Mary , et al. July 22, 2
2014-07-22
Anti-CD28 humanized Antibodies
App 20130078236 - Mary; Caroline ;   et al.
2013-03-28
Novel Alkynyl Derivatives As Modulators Of Metabotropic Glutamate Receptors
App 20120277237 - Bessis; Anne-Sophie ;   et al.
2012-11-01
Novel Alkynyl Derivatives As Modulators Of Metatropic Glutamate Receptors
App 20090124625 - Bessis; Anne-Sophie ;   et al.
2009-05-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed